---
title: "Etretinate - Psoriasis"
sidebar: mydoc_sidebar
permalink: db00926-mesh-d011565-1.html
toc: false 
---


Path ID: `DB00926_MESH_D011565_1`
{% include image.html url="images/db00926-mesh-d011565-1.png" file="db00926-mesh-d011565-1.png" alt="db00926-mesh-d011565-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D005050">MESH:D005050 </a> | Etretinate | Drug |
| <a href="https://identifiers.org/UniProt:P10276">UniProt:P10276 </a> | Retinoic acid receptor alpha | Protein |
| <a href="https://identifiers.org/UniProt:P10826">UniProt:P10826 </a> | Retinoic acid receptor beta | Protein |
| <a href="https://identifiers.org/UniProt:P19793">UniProt:P19793 </a> | Retinoic acid receptor RXR-alpha | Protein |
| <a href="https://identifiers.org/UniProt:P48443">UniProt:P48443 </a> | Retinoic acid receptor RXR-gamma | Protein |
| <a href="https://identifiers.org/GO:0031424">GO:0031424 </a> | Keratinization | BiologicalProcess |
| <a href="https://identifiers.org/GO:0010481">GO:0010481 </a> | Epidermal cell division | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D011565">MESH:D011565 </a> | Psoriasis | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Etretinate | INCREASES ACTIVITY OF | Retinoic Acid Receptor Alpha |
| Etretinate | INCREASES ACTIVITY OF | Retinoic Acid Receptor Beta |
| Etretinate | INCREASES ACTIVITY OF | Retinoic Acid Receptor Rxr-Alpha |
| Etretinate | INCREASES ACTIVITY OF | Retinoic Acid Receptor Rxr-Gamma |
| Retinoic Acid Receptor Alpha | NEGATIVELY REGULATES | Keratinization |
| Retinoic Acid Receptor Rxr-Alpha | NEGATIVELY REGULATES | Keratinization |
| Retinoic Acid Receptor Beta | NEGATIVELY REGULATES | Keratinization |
| Retinoic Acid Receptor Rxr-Gamma | NEGATIVELY REGULATES | Keratinization |
| Retinoic Acid Receptor Alpha | NEGATIVELY REGULATES | Epidermal Cell Division |
| Retinoic Acid Receptor Rxr-Alpha | NEGATIVELY REGULATES | Epidermal Cell Division |
| Retinoic Acid Receptor Beta | NEGATIVELY REGULATES | Epidermal Cell Division |
| Retinoic Acid Receptor Rxr-Gamma | NEGATIVELY REGULATES | Epidermal Cell Division |
| Keratinization | POSITIVELY CORRELATED WITH | Psoriasis |
| Epidermal Cell Division | POSITIVELY CORRELATED WITH | Psoriasis |
|---------|-----------|---------|

Comment: Withdrawn. Etretinate was taken off the market in Canada in 1996 and America in 1998 due to the risk of birth defects. Etretinate is now used to treat T-cell lymphomas.

Reference: 
  - [https://go.drugbank.com/drugs/DB00926](https://go.drugbank.com/drugs/DB00926)
